Diaceutics is riding a wave of precision medicine that tailors drugs to genetic and lifestyle factors, positioning itself as a key partner for pharma. The company now partners with 18 of the world’s top 20 drug makers, driving a 19% jump in recurring revenue to £20 million.

Pets at Home faces a retail slump as shoppers shift toward supermarkets, pushing the chain’s retail sales down 57.8% and cutting pre‑tax profit to £93 million. New CEO James Bailey’s aggressive price cuts have begun to lift volumes, and management projects pre‑tax profit near £100 million by 2027.

Autotrader Group warns that AI could let buyers find cars without needing paid listings, threatening its monopoly and shrinking revenue growth to 4% last year. The firm plans to return £600 million to shareholders this year, including £500 million of buybacks, while its share price has dropped 50%.

These shifts underscore how data‑driven precision and evolving consumer habits reshape pharma, pet retail, and automotive marketplaces, forcing each sector to rethink growth strategies and pricing models.